New Coverage: Surgery Partners’ Acquisitions, Leverage Present Risk, but Investors Adequately Compensated by S+375 Term Loan Maturing 2026 
Tue 09/19/2023 10:00 AM
Share this article:
Editor's Note: A prior version of this story referred to the Surgery Partners term loan as an L+375 term loan. In fact, on June 8, the company entered into an amendment to the credit agreement to transition the interest benchmark from LIBOR to SOFR, effective July 1. The headline and capital structure have been amended accordingly.

Kyle Owusu, CFA
Credit Research

Reorg’s performing credit analysis features B3 rated ambulatory surgery center, or ASC operator Surgery...
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2023 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!